Scarica l'app Stockscreener
4.42
8.49%
-0.41
Precedente Chiudi:
$4.83
Aprire:
$4.65
Volume 24 ore:
320.56K
Relative Volume:
0.60
Capitalizzazione di mercato:
$114.98M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-25.46%
1M Prestazione:
-29.62%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$4.39
$4.7627
Intervallo di 1 settimana:
$4.20
$6.3075
Portata 52W:
$4.20
$33.66
Liminatus Pharma Inc Stock (LIMN) Company Profile
Nome
Liminatus Pharma Inc
Settore
Industria
Telefono
213-273-5453
Indirizzo
6 CENTERPOINTE DR., LA PALMA
Confronta LIMN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LIMN
Liminatus Pharma Inc
|
4.42 | 127.20M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Liminatus Pharma Inc Borsa (LIMN) Ultime notizie
Liminatus Pharma Rings the Nasdaq Stock Market Closing Bell - Nasdaq
Liminatus Pharma Rings the Closing Bell - Nasdaq
Is it the right time to buy Liminatus Pharma Inc. stockOutstanding risk-reward balance - Jammu Links News
What institutional investors are buying Liminatus Pharma Inc. stockFree Stock Selection - Jammu Links News
Liminatus Pharma Inc. Stock Analysis and ForecastMaximize returns with disciplined trading - Jammu Links News
Why Liminatus Pharma Inc. stock attracts strong analyst attentionReal Profit Trade Plan Suggestions Shared Widely - beatles.ru
What makes Liminatus Pharma Inc. stock price move sharplyHigh-yield trading alerts - Jammu Links News
Why is Liminatus Pharma Inc. stock attracting strong analyst attentionHigh-yield trading alerts - Jammu Links News
How many analysts rate Liminatus Pharma Inc. Equity Warrant as a “Buy”Invest confidently with data-backed picks - Jammu Links News
What are the technical indicators suggesting about Liminatus Pharma Inc.Free Trend-Following Techniques - Jammu Links News
How does Liminatus Pharma Inc. generate profit in a changing economyAccelerated financial growth - Jammu Links News
How volatile is Liminatus Pharma Inc. Equity Warrant stock compared to the marketAchieve consistent double-digit growth - Jammu Links News
What drives Liminatus Pharma Inc. Equity Warrant stock priceInvest confidently with professional advice - Jammu Links News
How does Liminatus Pharma Inc. Equity Warrant generate profit in a changing economyFree Investment Case Studies - Jammu Links News
What is the dividend policy of Liminatus Pharma Inc. Equity Warrant stockStay ahead with advanced stock screening tools - Jammu Links News
Is Liminatus Pharma Inc. Equity Warrant stock overvalued or undervaluedBreakthrough capital growth - Jammu Links News
What catalysts could drive Liminatus Pharma Inc. stock higher in 2025Superior risk-adjusted returns - Jammu Links News
What are Liminatus Pharma Inc. company’s key revenue driversCapitalize on momentum stocks early - Jammu Links News
What are the latest earnings results for Liminatus Pharma Inc. Equity WarrantFree Popular Stock Recommendations - Jammu Links News
What are Liminatus Pharma Inc. Equity Warrant company’s key revenue driversInvest confidently with actionable market data - Jammu Links News
How strong is Liminatus Pharma Inc. company’s balance sheetUnlock powerful insights from market experts - Jammu Links News
How does Liminatus Pharma Inc. compare to its industry peersAchieve breakthrough financial growth - Jammu Links News
What are analysts’ price targets for Liminatus Pharma Inc. Equity Warrant in the next 12 monthsDiscover hidden gems in the stock market - Jammu Links News
What analysts say about Liminatus Pharma Inc. Equity Warrant stockDiscover breakthrough stocks before the crowd - Jammu Links News
What makes Liminatus Pharma Inc. Equity Warrant stock price move sharplyInvest smarter with data-backed insights - Jammu Links News
What is the risk reward ratio of investing in Liminatus Pharma Inc. Equity Warrant stockWealth Building Review That Work - jammulinksnews.com
What is Liminatus Pharma Inc. company’s growth strategyExpert Picks Outlook For Beginners - jammulinksnews.com
What catalysts could drive Liminatus Pharma Inc. Equity Warrant stock higher in 2025Expert Picks Planner For Fast Growth - Jammu Links News
Is Liminatus Pharma Inc. forming a reversal patternAI Based High Gain Watchlist Scanner Shared - metal.it
When is Liminatus Pharma Inc. stock expected to show significant growthChart Pattern Planner For Beginners - Jammu Links News
Liminatus Pharma Inc. Company’s Quarterly Earnings Growth: What the Numbers SayQuick Gain Stock Watch With Indicators Reviewed - metal.it
😱🔥Liminatus Enters Crypto: $500 Million BNB Bomb Explodes!🤯💲 - Binance
Three Major Companies Announce $1.7 Billion in BNB Treasury Allocations, CZ Reacts - Coinspeaker
How does Liminatus Pharma Inc. Equity Warrant compare to its industry peersFree Stock Target Finder That Work - jammulinksnews.com
Custom Dashboard Highlights Liminatus Pharma Inc. Equity Warrant Price MomentumBuy Alerts With Low Risk Confirmation Noted - metal.it
Liminatus Pharma Inc Azioni (LIMN) Dati Finanziari
Non sono disponibili dati finanziari per Liminatus Pharma Inc (LIMN). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.24%
3.39%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):